Hysterectomy Device Market Size, Share, Competitive Landscape and Trend Analysis Report, by Disease type, by Surgical approach, by End User : Global Opportunity Analysis and Industry Forecast, 2022-2031

Hysterectomy Device Market Research, 2031

The global hysterectomy device market size was valued at $328.1 million in 2021 and is projected to reach $566.5 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Hysterectomy devices are medical devices used in the surgical removal of the uterus. Hysterectomies are a common gynecological procedure, and the devices used in these procedures can vary depending on the type of surgery performed. This can be done for a variety of reasons, such as to treat gynecological conditions like uterine fibroids, endometriosis, and abnormal uterine bleeding, or to treat certain types of cancer. Hysterectomies can be performed through a variety of surgical techniques, including open surgery, laparoscopic surgery, and robotic-assisted surgery. The choice of surgical technique depends on a number of factors, including the patient's medical history, the reason for the hysterectomy, and the surgeon's preference. 

Market Dynamics

The hysterectomy device market trends which drive the growth of the market include the increased prevalence of uterine cancer, which is frequently treated by hysterectomy, which is anticipated to increase demand for these devices. Moreover, the popularity of minimally invasive hysterectomy devices including laparoscopic devices and robotic-assisted surgical systems has increased due to the shift towards minimally invasive surgery which further fuels the growth of the market. To address the rising demand for minimally invasive procedures, medical device manufacturers are investing in the creation of new and improved equipment. Minimally invasive procedures are becoming more acceptable since they are linked to quicker recovery periods, fewer pain and scarring side effects, and shorter hospital stays. Thus, increasing demand for minimally invasive procedures drives the hysterectomy device market growth. 

In addition, the rising emphasis on recognizing and meeting specific health requirements and concerns of women is referred to as the growth in awareness of women's health. There has been a considerable trend in the medical community recently toward acknowledging and addressing gender-specific health issues. Thus, an increase in awareness about women’s health propels the hysterectomy device industry growth. 

Furthermore, the growing focus on women's health issues in the media and the medical community is expected to drive greater awareness of the available treatment options, including hysterectomy, and further fuel demand for these devices. Women's health awareness campaigns may contribute to the growth of the hysterectomy market, it is important to prioritize individual medical needs and ensure that the decision to undergo this procedure is made in consultation with a healthcare provider. The increasing emphasis on women's health and the availability of more advanced and less invasive treatment options are expected to drive growth in the hysterectomy device industry during the forecast period.

In addition, the market for hysterectomy devices has grown significantly as a result of technological improvements. Due to the development of new and improved surgical techniques and tools, hysterectomy is now a safer, less invasive, and more practical treatment for female patients. Open surgery was used in traditional hysterectomy treatments, which required a significant incision and a lengthy healing period. Thus, the development of technology fuels the market. Additionally, owing to advancements in technology, the market for hysterectomy devices market growth is anticipated during the forecast period. 

Moreover, the rising prevalence of uterine cancer drives market growth. In addition to uterine cancer, hysterectomy is also used for the treatment of other gynecologic conditions such as uterine fibroids, endometriosis, and abnormal uterine bleeding. These conditions also contribute to the demand for hysterectomy procedures. Uterine cancer is the most common gynecologic cancer in women, and in some cases, a hysterectomy is the primary treatment option. For an instance, according to the National Cancer Institute, the rate of new cases of uterine cancer was 27.8 per 100,000 women per year. The death rate was 5.1 per 100,000 women per year. Approximately 3.1% of women will be diagnosed with uterine cancer at some point during their lifetime. Thus, the high prevalence of uterine cancer drives market growth. 

However, a hysterectomy is a major surgical procedure that requires specialized equipment and skilled healthcare professionals. The high cost of treatment and availability of alternative treatments are expected to restrain the growth of the hysterectomy device market. The total cost of a hysterectomy can include the cost of the surgery, anesthesia, hospital stay, and follow-up care, among other factors.  

Hysterectomy is a common and effective treatment for certain gynecologic conditions. It is a major surgical procedure that carries risks and can have long-term consequences, such as infertility and menopausal symptoms. Thus, the availability of alternative treatments can potentially restrain the growth of the hysterectomy device market as patients may adopt other treatments such as hormonal therapy or uterine artery embolization, which are less invasive and may offer faster recovery times.

On the other hand, the increasing demand for minimally invasive procedures and robotic-assisted surgeries is anticipated as the hysterectomy devices market opportunity during the forecast period. Minimally invasive procedures such as laparoscopic or robotic-assisted laparoscopic surgeries have gained popularity due to their potential benefits, including shorter hospital stays, lesser blood loss, and faster recovery times compared to traditional open surgery. The rise in demand for minimally invasive procedures is seen as an opportunity for the growth of the hysterectomy device market, as manufacturers develop new devices to meet the needs of these procedures. 

The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. Many hospitals and healthcare facilities canceled or postponed elective procedures, including hysterectomies, to conserve resources and reduce the risk of COVID-19 transmission. This may have resulted in decreased demand for hysterectomy devices during the pandemic. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The COVID-19 pandemic has had a considerable impact on the market for hysterectomy devices. The pandemic has disrupted supply chains, which has resulted in a shortage of medical supplies, particularly hysterectomies. This has made it difficult for medical staff to obtain the equipment they need to carry out surgery, resulting in cancellations or delays. 

Segmental Overview 

The hysterectomy device market size is segmented into disease type, surgical approach, end user, and region. By product type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain, and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic-assisted laparoscopic hysterectomy, and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

By Disease Type

The hysterectomy device market share is segmented into uterine cancer, fibroids, chronic pelvic pain, and others (uterine prolapse, endometriosis, adenomyosis) The uterine cancer segment dominated the global market in 2021 and is expected to remain dominant throughout the forecast period, owing to a high prevalence of uterine cancer. 

 By Surgical Approach

The hysterectomy device market analysis is segmented into vaginal hysterectomy, laparoscopic hysterectomy, robotic-assisted laparoscopic hysterectomy, and abdominal hysterectomy. The laparoscopic hysterectomy segment dominated the global market in 2021, owing to patients typically experience less pain, less scarring, and a shorter recovery time compared to traditional open surgery. And robotic-assisted laparoscopic hysterectomy is expected to witness growth owing to its precision, allowing for more targeted tissue dissection and reduced blood loss during surgery. 

By End User

The hysterectomy device market is classified into hospitals, ambulatory surgical centers, and others. The hospitals' segment held the largest market share in 2021 and is expected to remain dominant, owing to it offering diagnosis for the detection of diseases, preoperative care, and postoperative care, making it a one-stop-shop for patients undergoing hysterectomy procedures. The ambulatory surgical center centers segment is projected to register the highest CAGR owing to it being increasingly popular in recent years due to the focus on same-day surgeries and minimally invasive procedures.   

 By Region

The hysterectomy device market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major hysterectomy device market share in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major players, such as CooperCompanies, Jhonson & Jhonson and technological advancements in the region drive the growth of the market. 

In addition, surge in prevalence of uterine cancer in the region, which is expected to propel the market growth. Furthermore, the presence of well-established healthcare infrastructure and high purchasing power are expected to drive the market growth. Furthermore, acquisitions adopted by the key players in this region boost the growth of the market.  

Asia-Pacific is expected to grow at the highest rate during the hysterectomy device market forecast period. The market growth in this region is attributable to presence of pharmaceutical companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, Asia-Pacific offers profitable opportunities for key players operating in the hysterectomy device market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunities for new entrants in this region.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy devices market analysis from 2021 to 2031 to identify the prevailing hysterectomy devices market opportunities.
• Market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
• An in-depth analysis of the hysterectomy devices market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global hysterectomy devices market trends, key players, market segments, application areas, and market growth strategies.

  Hysterectomy Device Market Report Highlights

Aspects	Details
Market Size By 2031	USD 566.5 million
Growth Rate	CAGR of 5.6%
Forecast period	2021 - 2031
Report Pages	389
By Surgical approach	Laparoscopic hysterectomy Robotic assisted laparoscopic hysterectomy Abdominal hysterectomy Vaginal hysterectomy
By Disease type	Uterine Cancer Fibroids Chronic pelvic pain Others
By End User	Hospitals Ambulatory Surgical Centers Others
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	B. Braun Melsungen AG, Medtronic plc, Conkin surgical instruments ltd, KARL STORZ GmbH & Co. KG, Laborie, Inc, Cooper Companies, Inc., Richard Wolf GmbH, CONMED Corporation, fortimedix surgical b.v., Johnson & Johnson

Analyst Review

This section provides various opinions of top-level CXOs in the global hysterectomy device market. According to the insights of CXOs, increase in demand for hysterectomy market globally is expected to offer profitable opportunities for the expansion of the market. In addition, favorable government policies and schemes for women healthcare, has piqued the interest of several companies to develop advanced devices.  

CXOs further added that increase in uterine cancer in developing regions has largely contributed in the market revenue in 2021, and is expected to maintain this trend throughout the forecast period. In addition, awareness regarding use of hysterectomy device in treatment of diseases across globe, increase in demand of next generation devices in many countries significantly contributes towards the revenue generation.   

Furthermore, North America is expected to witness highest growth, in terms of revenue, owing to increase in awareness towards minimally invasive techniques and development of new advanced devices drives the market growth. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in investments for healthcare drives the growth of market during the forecast period. 

Author Name(s) : Ashwini Vijay Ghayal | Roshan Deshmukh

Related Tags

• Oncology
• Surgical Equipment
• Disposable Medical Supplies
• Cancer Therapy

^*Terms and Conditions Apply